0000000000280744
AUTHOR
Carmen Cámara
showing 3 related works from this author
On-line removal of mass interferences in palladium determination by ICP-MS using modified capillaries coupled to micro-flow nebulizers
2001
This paper describes a novel approach developed for on-line removal of interferences within modified capillaries coupled to micro-flow nebulizers, for palladium determination by inductively coupled plasma mass spectrometry (ICP-MS). A strong cation exchanger [2-(4-chlorosulfophenyl)ethyltrichlorosilane)] was covalently bound to the silica capillary that was coupled to a microconcentric nebulizer (MCN) or to a direct injection nebulizer (DIN). The modified surface of the capillary was able to selectively retain copper and yttrium from aqueous samples at pH 7.5 during the sample introduction step, while Pd was not retained and 105Pd could be determined in the absence of interferent elements. …
On-line Chloride Interference Removal for Arsenic Determination in Waste Water and Urine by ICP-MS Using a Modified Capillary
2002
The determination of arsenic in environmental samples like waste waters from industrial effluents and in biological samples like urine is very important due to the toxic nature of some of its species at moderate levels of exposure. The objective of this study was to evaluate the capability of modified anionic capillaries to remove chloride for ICP-MS determination of arsenic, which causes spectral interference due to formation of 40 Ar 35 Cl + . Also high chloride content gives non-spectral interferences. The results indicate that arsenic at a concentration higher than 1 µg L m 1 in a matrix with a chloride content up to 600 mg L m 1 can be accurately determined using a 3-aminopropyltrimeth…
Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.
2018
Background and objectives: Percentages of blood CD19 + CD5 + B cells and CD8 + perforin + T lymphocytes can predict response to Interferon (IFN)-beta treatment in relapsing-remitting multiple sclerosis (RRMS) patients. We aimed to standardize their detection in a multicenter study, prior to their implementation in clinical practice. Methods: Fourteen hospitals participated in the study. A reference centre was established for comparison studies. Peripheral blood cells of 105 untreated RRMS patients were studied. Every sample was analyzed in duplicate in the participating centre and in the reference one by flow cytometry. When needed, participating centres corrected fluorescence compensations…